Aura Biosciences (AURA) Competitors $6.05 +0.03 (+0.50%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$6.16 +0.11 (+1.74%) As of 10/3/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AURA vs. VCEL, AVDL, GPCR, SDGR, ABCL, JANX, RCUS, SNDX, ARDX, and STOKShould you be buying Aura Biosciences stock or one of its competitors? The main competitors of Aura Biosciences include Vericel (VCEL), Avadel Pharmaceuticals (AVDL), Structure Therapeutics (GPCR), Schrodinger (SDGR), AbCellera Biologics (ABCL), Janux Therapeutics (JANX), Arcus Biosciences (RCUS), Syndax Pharmaceuticals (SNDX), Ardelyx (ARDX), and Stoke Therapeutics (STOK). These companies are all part of the "pharmaceutical products" industry. Aura Biosciences vs. Its Competitors Vericel Avadel Pharmaceuticals Structure Therapeutics Schrodinger AbCellera Biologics Janux Therapeutics Arcus Biosciences Syndax Pharmaceuticals Ardelyx Stoke Therapeutics Aura Biosciences (NASDAQ:AURA) and Vericel (NASDAQ:VCEL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, media sentiment, institutional ownership and dividends. Which has more volatility & risk, AURA or VCEL? Aura Biosciences has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Comparatively, Vericel has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Do analysts prefer AURA or VCEL? Aura Biosciences currently has a consensus price target of $22.00, suggesting a potential upside of 263.64%. Vericel has a consensus price target of $60.40, suggesting a potential upside of 86.19%. Given Aura Biosciences' stronger consensus rating and higher probable upside, research analysts clearly believe Aura Biosciences is more favorable than Vericel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aura Biosciences 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.78Vericel 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do insiders and institutionals hold more shares of AURA or VCEL? 96.8% of Aura Biosciences shares are held by institutional investors. 6.3% of Aura Biosciences shares are held by company insiders. Comparatively, 7.2% of Vericel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better earnings & valuation, AURA or VCEL? Vericel has higher revenue and earnings than Aura Biosciences. Aura Biosciences is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAura BiosciencesN/AN/A-$86.92M-$1.96-3.09Vericel$237.22M6.90$10.36M$0.12270.33 Does the media refer more to AURA or VCEL? In the previous week, Aura Biosciences had 1 more articles in the media than Vericel. MarketBeat recorded 2 mentions for Aura Biosciences and 1 mentions for Vericel. Vericel's average media sentiment score of 1.76 beat Aura Biosciences' score of 0.40 indicating that Vericel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aura Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Vericel 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is AURA or VCEL more profitable? Vericel has a net margin of 2.85% compared to Aura Biosciences' net margin of 0.00%. Vericel's return on equity of 2.47% beat Aura Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Aura BiosciencesN/A -64.44% -54.24% Vericel 2.85%2.47%1.69% SummaryVericel beats Aura Biosciences on 9 of the 15 factors compared between the two stocks. Get Aura Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AURA vs. The Competition Export to ExcelMetricAura BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$375.83M$3.36B$6.12B$10.58BDividend YieldN/A2.28%5.65%4.70%P/E RatioN/A22.2886.9626.71Price / SalesN/A461.37605.42130.98Price / CashN/A47.8637.9061.31Price / Book1.999.9312.556.55Net Income-$86.92M-$52.80M$3.31B$277.50M7 Day Performance-1.79%5.22%4.28%2.42%1 Month Performance-6.64%10.61%6.90%8.63%1 Year Performance-30.62%25.03%70.54%31.60% Aura Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AURAAura Biosciences1.9002 of 5 stars$6.05+0.5%$22.00+263.6%-30.6%$375.83MN/A0.0050News CoveragePositive NewsVCELVericel3.1547 of 5 stars$31.79+5.2%$60.40+90.0%-25.2%$1.53B$249.12M264.94300Positive NewsAVDLAvadel Pharmaceuticals3.1255 of 5 stars$15.31-0.2%$20.86+36.2%+14.7%$1.49B$221.08M-510.3370Positive NewsGPCRStructure Therapeutics3.0991 of 5 stars$25.30+1.2%$68.67+171.4%-36.5%$1.44BN/A-24.10136SDGRSchrodinger3.3736 of 5 stars$20.04+3.8%$27.83+38.9%+17.6%$1.42B$207.54M-8.08790News CoverageAnalyst DowngradeABCLAbCellera Biologics3.197 of 5 stars$4.87+2.7%$8.00+64.3%+136.0%$1.42B$28.83M-8.85500News CoverageGap UpJANXJanux Therapeutics2.2403 of 5 stars$23.70+2.0%$78.31+230.4%-46.7%$1.40B$439K-13.1730RCUSArcus Biosciences1.6256 of 5 stars$13.34+3.9%$21.14+58.5%-19.8%$1.37B$258M-4.21500SNDXSyndax Pharmaceuticals3.6997 of 5 stars$15.56-0.8%$39.22+152.1%-17.1%$1.35B$23.68M-4.00110Analyst RevisionARDXArdelyx4.107 of 5 stars$5.63+1.6%$11.70+107.8%-22.9%$1.34B$333.61M-24.4890STOKStoke Therapeutics2.6972 of 5 stars$24.73+2.4%$25.57+3.4%+116.8%$1.32B$36.56M29.09100 Related Companies and Tools Related Companies Vericel Competitors Avadel Pharmaceuticals Competitors Structure Therapeutics Competitors Schrodinger Competitors AbCellera Biologics Competitors Janux Therapeutics Competitors Arcus Biosciences Competitors Syndax Pharmaceuticals Competitors Ardelyx Competitors Stoke Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AURA) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aura Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aura Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AURA Stock Alerts